Ovarian Yolk Sac Tumors: Is Fertility Preservation Possible?
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Ovarian yolk sac tumors, a type of malignant germ cell tumor, often present with high alpha-fetoprotein (AFP) levels. Early diagnosis and treatment, including surgery and chemotherapy (BEP), are crucial for successful outcomes and potential fertility preservation.
Area Of Science
- Gynecologic Oncology
- Reproductive Endocrinology
- Pediatric Oncology
Background
- Yolk sac tumors constitute 14-20% of malignant ovarian germ cell tumors.
- Elevated serum alpha-fetoprotein (AFP) is a hallmark, aiding in treatment monitoring and surveillance.
- Diagnosis, staging, and treatment necessitate surgical intervention.
Observation
- Three cases of ovarian yolk sac tumors in young females (12, 21, and 25 years old) are presented.
- Patients exhibited symptoms like abdominal pain and distension with large pelvic masses on ultrasonography.
- Significantly elevated AFP levels were noted in all cases (ranging from 8700 mg/ml to 1000 mg/ml).
Findings
- Histopathological diagnosis confirmed ovarian yolk sac tumors.
- Patients underwent surgical procedures such as salpingo-oophorectomy, omentectomy, and lymphadenectomy.
- Chemotherapy regimens, including bleomycin, etoposide, and cisplatin (BEP), were administered, leading to decreased AFP levels and successful treatment.
Implications
- These cases highlight the importance of considering ovarian yolk sac tumors in young patients with rapidly growing ovarian masses and elevated AFP.
- The study underscores the curability of yolk sac tumors, even in pediatric populations.
- Fertility preservation strategies in the context of ovarian yolk sac tumor treatment are emphasized.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...